News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
512,067 Results
Type
Article (25682)
Company Profile (167)
Press Release (486218)
Section
Business (157143)
Career Advice (1547)
Deals (26851)
Drug Delivery (39)
Drug Development (49502)
Employer Resources (98)
FDA (11590)
Job Trends (10685)
News (248252)
Policy (19204)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (2)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1897)
Accelerated approval (1)
Adcomms (8)
Allergies (43)
Alliances (41782)
ALS (44)
Alzheimer's disease (829)
Antibody-drug conjugate (ADC) (69)
Approvals (11599)
Artificial intelligence (237)
Autoimmune disease (4)
Automation (11)
Bankruptcy (196)
Best Places to Work (8787)
BIOSECURE Act (8)
Biosimilars (27)
Biotechnology (131)
Bladder cancer (35)
Brain cancer (18)
Breast cancer (153)
Cancer (1278)
Cardiovascular disease (86)
Career advice (1286)
Career pathing (18)
CAR-T (111)
Cell therapy (313)
Cervical cancer (9)
Clinical research (39478)
Collaboration (668)
Compensation (254)
Complete response letters (9)
COVID-19 (1518)
CRISPR (38)
C-suite (167)
Cystic fibrosis (90)
Data (1325)
Decentralized trials (1)
Denatured (18)
Depression (21)
Diabetes (130)
Diagnostics (5726)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (26)
Drug discovery (90)
Drug pricing (25)
Drug shortages (5)
Duchenne muscular dystrophy (53)
Earnings (61616)
Editorial (7)
Employer branding (17)
Employer resources (88)
Events (79154)
Executive appointments (520)
FDA (12362)
Featured Employer (39)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (557)
Gene editing (96)
Generative AI (23)
Gene therapy (223)
GLP-1 (323)
Government (1996)
Grass and pollen (1)
Guidances (35)
Healthcare (13747)
Huntington's disease (9)
IgA nephropathy (11)
Immunology and inflammation (44)
Indications (15)
Infectious disease (1602)
Inflammatory bowel disease (85)
Inflation Reduction Act (4)
Influenza (33)
Intellectual property (63)
Interviews (248)
IPO (12659)
IRA (11)
Job creations (2281)
Job search strategy (1087)
Kidney cancer (6)
Labor market (16)
Layoffs (228)
Leadership (9)
Legal (4371)
Liver cancer (40)
Lung cancer (165)
Lymphoma (81)
Machine learning (2)
Management (30)
Manufacturing (186)
MASH (32)
Medical device (12303)
Medtech (12308)
Mergers & acquisitions (14583)
Metabolic disorders (315)
Multiple sclerosis (35)
NASH (8)
Neurodegenerative disease (46)
Neuropsychiatric disorders (7)
Neuroscience (1115)
NextGen: Class of 2025 (4767)
Non-profit (2506)
Northern California (1763)
Now hiring (13)
Obesity (146)
Opinion (140)
Ovarian cancer (51)
Pain (58)
Pancreatic cancer (47)
Parkinson's disease (86)
Partnered (13)
Patents (151)
Patient recruitment (65)
Peanut (27)
People (45449)
Pharmaceutical (25)
Pharmacy benefit managers (2)
Phase I (13280)
Phase II (17548)
Phase III (12604)
Pipeline (753)
Podcasts (40)
Policy (36)
Postmarket research (1222)
Preclinical (5838)
Press Release (72)
Prostate cancer (54)
Psychedelics (10)
Radiopharmaceuticals (201)
Rare diseases (281)
Real estate (4375)
Recruiting (40)
Regulatory (13932)
Reports (26)
Research institute (1843)
Resumes & cover letters (317)
Rett syndrome (3)
RNA editing (1)
RSV (23)
Schizophrenia (31)
Series A (102)
Series B (63)
Service/supplier (9)
Sickle cell disease (34)
Southern California (1535)
Special edition (7)
Spinal muscular atrophy (138)
Sponsored (20)
Startups (3023)
State (2)
Stomach cancer (2)
Supply chain (30)
The Weekly (21)
United States (15411)
Vaccines (375)
Venture capitalists (22)
Webinars (10)
Weight loss (65)
Women's health (18)
Worklife (6)
Date
Last 7 days (403)
Last 30 days (1783)
Last 365 days (24966)
2025 (5676)
2024 (26481)
2023 (30935)
2022 (41227)
2021 (43948)
2020 (41598)
2019 (34851)
2018 (26289)
2017 (25328)
2016 (24088)
2015 (28742)
2014 (21804)
2013 (18218)
2012 (19419)
2011 (20029)
2010 (18687)
Location
Africa (527)
Alabama (45)
Alaska (7)
Arizona (147)
Arkansas (11)
Asia (30070)
Australia (5183)
California (4029)
Canada (1404)
China (277)
Colorado (199)
Connecticut (213)
Delaware (57)
Europe (66267)
Florida (593)
Georgia (148)
Idaho (46)
Illinois (327)
India (14)
Indiana (239)
Iowa (6)
Japan (118)
Kansas (86)
Kentucky (14)
Louisiana (7)
Maine (57)
Maryland (564)
Massachusetts (3064)
Michigan (197)
Minnesota (303)
Mississippi (2)
Missouri (67)
Montana (30)
Nebraska (20)
Nevada (40)
New Hampshire (66)
New Jersey (1102)
New Mexico (23)
New York (1107)
North Carolina (692)
North Dakota (7)
Northern California (1763)
Ohio (140)
Oklahoma (12)
Oregon (22)
Pennsylvania (837)
Puerto Rico (7)
Rhode Island (23)
South America (760)
South Carolina (17)
South Dakota (1)
Southern California (1535)
Tennessee (68)
Texas (572)
Utah (134)
Virginia (93)
Washington D.C. (21)
Washington State (381)
West Virginia (3)
Wisconsin (41)
512,067 Results for "applied genetic technologies corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics
January 30, 2025
·
5 min read
Complete response letters
Applied Therapeutics Crashes After FDA Rejection of Rare Disease Drug
After extending its review period to evaluate additional submissions, the FDA ultimately denied Applied Therapeutics’ govorestat for galactosemia, citing “deficiencies” with the application. The biotech plans to meet with the regulator to discuss the best way forward for the drug.
December 2, 2024
·
3 min read
·
Tristan Manalac
Gene therapy
Regeneron’s Gene Therapy Restores Hearing in Patients with Rare Genetic Condition
The treatment, called DB-OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic deafness.
February 24, 2025
·
4 min read
·
Dan Samorodnitsky
BioMidwest
Applied Genetic Technologies Corporation Urges Shareholders to Tender Their Shares by November 28, 2022
Applied Genetic Technologies Corporation, President and Chief Executive Officer, Sue Washer, sent the following letter to stockholders.
November 14, 2022
·
5 min read
Press Releases
Myriad Genetics Issues Quality, Innovation, and Corporate Responsibility Report
January 7, 2025
·
3 min read
Regulatory
FDA Warns Applied Therapeutics of ‘Objectionable Conditions’ in Govorestat Study
The agency’s warning letter outlines Applied Therapeutics’ failure to provide adequate information regarding the clinical trial—including a dosing error for govorestat—claims that the company said it had already addressed.
December 4, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
December 17, 2024
·
15 min read
BioMidwest
Applied Genetic Technologies Corporation Reminds Shareholders to Tender Their Shares by November 28, 2022
Applied Genetic Technologies Corporation, President and Chief Executive Officer, Sue Washer, sent the following letter to shareholders:
November 3, 2022
·
6 min read
Press Releases
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
March 25, 2025
·
3 min read
Press Releases
Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio
February 25, 2025
·
6 min read
1 of 51,207
Next
